We’re making precision diagnostics accessible around the planet.
One disease at the time — starting with Breast Cancer Prognosis
Our molecular technology makes diagnosing complex diseases simple. No need for laborious tests and expensive machines, our kits bring molecular intelligence to widely accessible PCR equipment.
Traditional PCR can’t keep up with modern medicine.
Conventional PCR tests detect one or two biomarkers — ideal for infections, but not for cancers or chronic diseases that depend on complex molecular patterns.
To capture these patterns today, samples must be sent to specialised central laboratories, where analysis depends on sophisticated equipment, complex workflows, expert staff, and multi-step data processing.
The result: high costs, long turnaround times, and limited access to precision diagnostics outside major reference centres — creating a real bottleneck for precision medicine adoption and leading to underserved disease areas.
We simplify precision molecular diagnostics — without compromise.
Signatur Biosciences’ platform transforms standard qPCR machines into powerful precision diagnostic tools.
By condensing complex RNA signatures into a single PCR assay, we make precision diagnostics decentralised, faster, and more affordable — while maintaining the same clinical utility as reference-lab genomic assays.
Built for compatibility with standard qPCR machines and workflows, our kits integrate seamlessly into existing hospital infrastructure, enabling clinicians to deliver precision insights within days, not weeks.
